Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Cash Flows From Operating Activities | |||||
Net Income | 3,197,000 | 2,456,000 | 5,687,000 | 7,513,000 | 4,766,000 |
Depreciation Amortization | 1,005,000 | 503,000 | 1,765,000 | 1,323,000 | 888,000 |
Income taxes - deferred | 72,000 | N/A | -1,517,000 | N/A | N/A |
Accounts receivable | -96,000 | -316,000 | -591,000 | -806,000 | -805,000 |
Accounts payable and accrued liabilities | -366,000 | 94,000 | 734,000 | 881,000 | 12,000 |
Other Working Capital | -1,850,000 | -495,000 | 467,000 | -295,000 | -1,412,000 |
Other Operating Activity | 3,532,000 | 775,000 | 6,882,000 | 1,419,000 | 2,062,000 |
Operating Cash Flow | $5,494,000 | $3,017,000 | $13,427,000 | $10,035,000 | $5,511,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -235,000 | -107,000 | -638,000 | -515,000 | -233,000 |
Net Acquisitions | -440,000 | -320,000 | -736,000 | -541,000 | -401,000 |
Purchase Of Investment | -558,000 | -194,000 | -1,792,000 | -1,581,000 | -637,000 |
Sale Of Investment | 1,066,000 | 594,000 | 2,160,000 | 1,914,000 | 1,511,000 |
Investing Cash Flow | $-167,000 | $-27,000 | $-1,006,000 | $-723,000 | $240,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | -393,000 | -200,000 | 3,301,000 | 2,602,000 | 3,111,000 |
Debt Issued | 0 | N/A | 5,963,000 | 5,963,000 | N/A |
Debt Repayment | -4,000 | N/A | -6,035,000 | -5,021,000 | -3,013,000 |
Common Stock Issued | 5,000 | 4,000 | 73,000 | 66,000 | 64,000 |
Common Stock Repurchased | -623,000 | -620,000 | -12,014,000 | -9,956,000 | -8,947,000 |
Dividend Paid | -3,180,000 | -1,588,000 | -5,580,000 | -4,129,000 | -2,668,000 |
Other Financing Activity | -3,258,000 | -2,979,000 | -104,000 | -96,000 | -34,000 |
Financing Cash Flow | $-7,453,000 | $-5,383,000 | $-14,396,000 | $-10,571,000 | $-11,487,000 |
Exchange Rate Effect | 9,000 | 1,000 | -39,000 | -29,000 | -20,000 |
Beginning Cash Position | 7,289,000 | 7,289,000 | 9,303,000 | 9,303,000 | 9,303,000 |
End Cash Position | 5,172,000 | 4,897,000 | 7,289,000 | 8,015,000 | 3,547,000 |
Net Cash Flow | $-2,117,000 | $-2,392,000 | $-2,014,000 | $-1,288,000 | $-5,756,000 |
Free Cash Flow | |||||
Operating Cash Flow | 5,494,000 | 3,017,000 | 13,427,000 | 10,035,000 | 5,511,000 |
Capital Expenditure | -235,000 | -107,000 | -638,000 | -515,000 | -233,000 |
Free Cash Flow | 5,259,000 | 2,910,000 | 12,789,000 | 9,520,000 | 5,278,000 |